Overview
Cofactor combines scientific expertise with business insight to turn research into market-ready solutions. Its team of scientists and industry specialists develops biotechnological solutions.
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 69 days for 2021).
- 202516/07/2026
- 202414/07/2025
- 202312/07/2024
- 202214/07/2023
- 202122/09/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to represent the company independently. If the management board is multi-member, the following are authorised to represent the company: the President of the Management Board independently, the Vice-President of the Management Board independently, and a member of the management board acting jointly with the President of the Management Board or the Vice-President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Koczorowskaage 71 | 50 | $675.31 | 50% |
Filip Witold Porzucekage 38 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-03-01.
13 1090 1463 0000 0001 4459 5854- 08 1090 1463 0000 0001 3409 2881
- 23 1090 1463 0000 0001 3409 2902
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $3,788.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,400$2,400 | Polski Fundusz Rozwoju S.A. | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $53$53 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $53$53 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $589,673.84 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| FcbiotechS.A. | $246,877.92 | fcbiotech.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| New Valuesp. z o.o. | $64,335.86 | new-value.pl | ||
| Opessp. z o.o. | $56,182.11 | opes.com.pl | ||
| KUL Creativesp. z o.o. | $39,507.00 | creative.kul.pl | ||
| Data2biologysp. z o.o. | $28,567.58 | data2biology.com |
FAQ
Last updated: 2026-07-17